Atlas FDA

Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device (Solitaire Revascularization Device)

FDA 510(k) clearance K193576 · decided 2020-11-20

Clearance details

K-number
K193576
Device name
Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device (Solitaire Revascularization Device)
Applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Decision
Substantially Equivalent
Date received
2019-12-23
Decision date
2020-11-20
Days to decision
333 days
Clearance type
Traditional
Product code
POL
Device class
2
Regulation number
882.5600
Medical specialty
Neurology
Advisory committee
Neurology
Location
Irvine, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Micro Therapeutics

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy Device (K242676)Phenox Limited2025-02-28
pRESET LITE Thrombectomy Device (K231539)Phenox Limited2023-10-21
Trevo NXT ProVue Retriever (K223305)Stryker Neurovascular2023-03-29
pRESET Thrombectomy Device (K222848)Phenox Limited2023-01-20
Trevo NXT ProVue Retriever (K210502)Stryker Neurovascular2021-08-27
Solitaire X Revascularization Device (K203358)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-03-01
Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever (K203219)Stryker Neurovascular2020-12-29
Trevo NXT ProVue Retriever (K200117)Stryker2020-02-07
Trevo NXT ProVue Retriever (K192207)Stryker2019-11-22
Trevo XP ProVue Retriever (K190779)Stryker2019-06-25
Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) (K181807)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2019-03-06
Solitaire 4 Revascularization Device (K183022)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2019-01-29

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Pipeline™ Vantage Embolization Device with Shield Technology™ (P100018/S048)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2025-08-14
Pipeline™ Flex Embolization Device (Pipeline™ Flex); Pipeline™ Flex Embolization Device with Shield Technology™ (Pipelin (P100018/S051)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2025-06-04
Pipeline Flex Embolization Device; Pipeline Flex Embolization Device with Shield Technology (Pipeline™ Shield) (P100018/S050)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2025-03-27
Pipeline™ Vantage Embolization Device with Shield Technology™ (Pipeline™ Vantage) (P100018/S049)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2025-03-05
Pipeline™ Flex Embolization Device with Shield Technology™, Pipeline™ Vantage Embolization Device with Shield Technology (P100018/S047)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-09-20
Pipeline™ Flex Embolization Device with Shield Technology™, Pipeline™ Vantage Embolization Device with Shield Technology (P100018/S046)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-07-26
Pipeline™ Vantage Embolization Device with Shield Technology™ (P100018/S043)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-06-06
Pipeline™ Flex Embolization Device with Shield Technology™ (PED2), Pipeline™ Vantage Embolization Device with Shield Tec (P100018/S044)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-04-25